1-7 December 2016 is Crohn’s and Colitis Awareness Week!
Crohn’s and Colitis are often described as the ‘invisible illness’. Every 30 minutes someone in the UK is diagnosed with Crohn’s disease or Ulcerative Colitis (the two main forms of Irritable Bowel Disease (IBD)). Our mission is to make health information clear and underline the importance of using medicines properly for people with long-term illnesses.
Signs and symptoms of Crohn’s and Colitis
The symptoms range from mild to severe and can change over time. However, the most common are:
• mouth ulcers
• feeling very tired
• stomach pain and diarrhoea
• loss of appetite and weight loss
• reduced level of red blood cells (anaemia)
• feeling generally unwell or high temperature.
Many of the medicines used to help control IBD are “anti-inflammatory” medicines. These include:
• 5-aminosalicylic acids (5-ASAs)
• biological drugs like infliximab and adalimumab
• immunosuppressants such as methotrexate and ciclosporin
Having clear information can help people take their medicines safely. Clear information can also make them more aware of the side effects and know what to do if they need help.
How Luto can help?
In the UK, since 1999 Patient Information Leaflets or PILs have been a legal requirement for all medicines. Results from studies from the Medicines and Healthcare products Regulatory Agency (MHRA) indicate that patients require more information than currently provided. The results showed the importance of the PIL which comes with the medicine rated more highly than any other source of information except doctors and pharmacists.
With so much importance on medicines for Crohn’s disease to minimise symptoms it is imperative that the Package Leaflets are as clear and concise as possible. Luto has unparalleled experience of reviewing and testing Package Leaflets for a wide range of medicines and prides itself on creating health information that is easy to read and understand.
Call the team today to find out how we can help you make your health information clear.